Luke Moore
Impact in
- Applied Microbiology and Biotechnology top 0.01%
- Antibiotic Use and Resistance
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 39
-
- SARS-CoV-2 detection and testing 7
- Antimicrobial Resistance in Staphylococcus 6
- COVID-19 Clinical Research Studies 5
- Co-authors
- Alison Holmes (51 shared papers)Timothy M. Rawson (31 shared papers)Abhilasha Karkey (1 shared paper)Arnfinn Sundsfjord (1 shared paper)Philippe J. Guérin (1 shared paper)Laura J. V. Piddock (1 shared paper)Sadie Regmi (1 shared paper)Martin Steinbakk (1 shared paper)
- Journals
- Journal of Antimicrobial Chemotherapy (10 papers)BMC Infectious Diseases (6 papers)Clinical Microbiology and Infection (6 papers)Journal of Hospital Infection (6 papers)Scientific Reports (4 papers)
- Partner nations
- United KingdomUnited StatesSouth Africa
In The Last Decade
Luke Moore
138 papers receiving 6.6k citations
Luke Moore's Hit Papers
Peers
Comparison fields: 5 of 177
- Applied Microbiology and Biotechnology 2.3k
- Molecular Medicine 1.3k
- Infectious Diseases 1.3k
- Critical Care and Intensive Care Medicine 308
- Clinical Biochemistry 366
Countries citing papers authored by Luke Moore
This map shows the geographic impact of Luke Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Moore more than expected).
Fields of papers citing papers by Luke Moore
This network shows the impact of papers produced by Luke Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Moore. The network helps show where Luke Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Understanding the mechanisms and drivers of antimicrobial resistance Hit paper breakdown → | 2015 | 1844 |
| 2 | Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing Hit paper breakdown → | 2020 | 1128 |
| 3 | Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting Hit paper breakdown → | 2020 | 460 |
| 4 | 2020 | 223 | |
| 5 | 2020 | 205 | |
| 6 | 2017 | 136 | |
| 7 | An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations Hit paper breakdown → | 2023 | 123 |
| 8 | 2015 | 119 | |
| 9 | 2011 | 99 | |
| 10 | 2016 | 97 | |
| 11 | 2014 | 92 | |
| 12 | 2013 | 89 | |
| 13 | 2016 | 80 | |
| 14 | 2020 | 77 | |
| 15 | 2021 | 75 | |
| 16 | 2010 | 70 | |
| 17 | 2020 | 65 | |
| 18 | 2020 | 62 | |
| 19 | 2012 | 62 | |
| 20 | 2015 | 59 |
About Luke Moore
Luke Moore is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Epidemiology, Molecular Medicine and Clinical Biochemistry, having authored 147 papers that have together received 6.8k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (39 papers), Antibiotic Resistance in Bacteria (16 papers), Bacterial Identification and Susceptibility Testing (12 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), SARS-CoV-2 detection and testing (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), COVID-19 Clinical Research Studies (5 papers) and Nosocomial Infections in ICU (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (2.3k citations), Molecular Medicine (1.3k citations), Infectious Diseases (1.3k citations), Critical Care and Intensive Care Medicine (308 citations) and Clinical Biochemistry (366 citations). Luke Moore has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include Alison Holmes, Timothy M. Rawson, Abhilasha Karkey, Arnfinn Sundsfjord, Philippe J. Guérin, Laura J. V. Piddock, Sadie Regmi, Martin Steinbakk, Mark Gilchrist and Nabeela Mughal. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, BMC Infectious Diseases, Clinical Microbiology and Infection, Journal of Hospital Infection and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.